Latest News & Updates

Breaking News

  • 4 hours ago

  • Vaibhavi M.

Tempest Completes CAR-T Acquisition And Financing Deal To Expand Oncology Pipeline, Strengthens Cell Therapy Portfolio
Breaking News
Adial Applauds U.S. Law Directing FDA To Expand Trial Endpoints For Addiction Drugs, Law Pushing NIDA Toward New Measures For Alcohol Use Disorder Therapies

Vaibhavi M.

LeonaBio Names Mark F. Kubik Chief Business Officer To Lead Licensing, Partnerships And Corporate Development As Company Pushes Phase 3 Lasofoxifene For Metastatic Breast Cancer Forward

Simantini Singh Deo

Rigel Appoints Veteran Pharma Executive Michael Miller To Board Of Directors

Vaibhavi M.

MetaVia Taps AI Platform To Uncover New Disease Targets For Vanoglipel, Syntekabio Collaboration Highlights Inflammation, Cancer Potential For MetaVia’s Lead Drug

Simantini Singh Deo

Other trending news you may like to read

Tempest Completes CAR-T Acquisition And Financing Deal To Expand Oncology Pipeline, Strengthens Cell Therapy Portfolio

Tempest completes CAR-T acquisition and financing deal, expanding its oncology and cell therapy pipeline.

Vaibhavi M.

Pharma Now

Adial Applauds U.S. Law Directing FDA To Expand Trial Endpoints For Addiction Drugs, Law Pushing NIDA Toward New Measures For Alcohol Use Disorder Therapies

Adial backs new U.S. law urging FDA to expand clinical trial endpoints for addiction and alcohol use disorder drugs.

Vaibhavi M.

Pharma Now

LeonaBio Names Mark F. Kubik Chief Business Officer To Lead Licensing, Partnerships And Corporate Development As Company Pushes Phase 3 Lasofoxifene For Metastatic Breast Cancer Forward

LeonaBio appoints Mark F. Kubik as CBO to drive business development and support Phase 3 lasofoxifene progress.

Simantini Singh Deo

Pharma Now

Rigel Appoints Veteran Pharma Executive Michael Miller To Board Of Directors

Rigel adds Michael P. Miller to its Board, bringing four decades of pharma commercial and leadership experience.

Vaibhavi M.

Pharma Now